"Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate. Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease." Scope of the Report: This report focuses on the Onychomycosis (Tinea Unguium) Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Johnson & Johnson GSK Novartis Pfizer Valeant Pharma Kaken Pharmaceutical Galderma Xiuzheng Pharmaceutical Letai Qilu Pharmaceutical Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Oral External Market Segment by Applications, can be divided into Age under 18 Age 18-50 Age above 50 There are 15 Chapters to deeply display the North America Onychomycosis (Tinea Unguium) Drug market. Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Onychomycosis (Tinea Unguium) Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Onychomycosis (Tinea Unguium) Drug, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Onychomycosis (Tinea Unguium) Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Onychomycosis (Tinea Unguium) Drug Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Onychomycosis (Tinea Unguium) Drug Introduction 1.2 Market Analysis by Type 1.2.1 Oral 1.2.2 External 1.3 Market Analysis by Applications 1.3.1 Age under 18 1.3.2 Age 18-50 1.3.3 Age above 50 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect (2012-2022)
